Mobile Diagnostics Without Compromise

The Challenges are Global

Clinicians need critical diagnostics earlier to empower the best, actionable care pathways.

The Value is Real

Empowered clinicians give millions the opportunity of timely treatment and improved patient outcomes.

Our Goal

Is to bring trusted diagnostics to the point of initial patient interaction, to expand access of quality healthcare to new settings, no matter where that patient interaction occurs

Nanomix Goals


Internal Link

Nanōmix Appoints Life Sciences Executive Thomas Schlumpberger as Chief Executive Officer and Member of the Board of Directors

Nanōmix announced the appointment of Dr. Thomas Schlumpberger as Chief Executive Officer and as a member of the Board of Directors, effective immediately.

Internal Link

Nanōmix Announces Distribution Agreement for the eLab® System with Biotron Ltd. in Israel

Biotron will market and distribute the Nanōmix eLab® system in Israel including the Nanomix S1 Panel cartridge and future new product cartridges for the eLab® system.

Internal Link

Schedule Your Demo at AACC 2022 of the Nanōmix eLab® system.

Critical Host Response Diagnostics in Minutes. Hand-held, Multiplex Immunoassay from a Single Sample.

Internal Link

Nanōmix Initiates New Clinical Study for the eLab® S1 Panel

Study incorporates the use of the Nanōmix eLab® S1 Panel within the Emergency Department of Hospital Clinico San Carlos in Madrid, Spain

Internal Link

Nanōmix Receives IVDR Certification for the eLab® Analyzer

IVDR certification enables Nanōmix to market its eLab® analyzer in the European Union under the newly established regulatory guidelines

External Link

Nanōmix Announces Three new Customer and Distributor Congress locations and dates.

ECCMID in Portugal

Apr 23 - 26, 2022

AACC in Chicago

Jul 26 - 28, 2022

Medica in Dusseldorf

Nov 14 - 17, 2022